Location History:
- Taipa, MO (2020)
- Guangzhou, CN (2014 - 2022)
Company Filing History:
Years Active: 2014-2022
Title: Shuwen Liu: Innovator in Pharmaceutical Chemistry
Introduction
Shuwen Liu is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex scientific challenges.
Latest Patents
Shuwen Liu holds three patents, with his latest innovations focusing on the synthesis and application of specific chemical derivatives. One of his notable patents involves 1,4-diphenyl-1H-imidazole and 2,4-diphenylthiazole derivatives. These compounds are designed for use as anti-inflammatory adjuvants and TLR1 or TLR2 agonists, which play a crucial role in immune response modulation. Additionally, he has developed a crystalline contrast agent for magnetic resonance imaging, which is prepared using a zwitterionic carboxylic pyridyl ligand. This agent exhibits superior properties, including high water-stability and low cytotoxicity, making it suitable for in vivo imaging applications.
Career Highlights
Throughout his career, Shuwen Liu has worked with esteemed institutions such as Southern Medical University and Macau University of Science and Technology. His research has not only advanced the field of pharmaceutical chemistry but has also contributed to the development of practical applications in medical imaging and therapeutic interventions.
Collaborations
Shuwen Liu has collaborated with notable colleagues, including Kui Eng Cheng and Gengzhen Zhu. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in their respective fields.
Conclusion
Shuwen Liu's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in medical applications and therapeutic solutions.